These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17427204)
1. Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring. Thall PF; Wooten LH; Logothetis CJ; Millikan RE; Tannir NM Stat Med; 2007 Nov; 26(26):4687-702. PubMed ID: 17427204 [TBL] [Abstract][Full Text] [Related]
2. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation. Lewis RJ; Lipsky AM; Berry DA Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241 [TBL] [Abstract][Full Text] [Related]
3. Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments. Thall PF; Wathen JK Stat Med; 2005 Jul; 24(13):1947-64. PubMed ID: 15806621 [TBL] [Abstract][Full Text] [Related]
4. Implementing a decision-theoretic design in clinical trials: why and how? Palmer CR; Shahumyan H Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801 [TBL] [Abstract][Full Text] [Related]
5. Continuous Bayesian adaptive randomization based on event times with covariates. Cheung YK; Inoue LY; Wathen JK; Thall PF Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549 [TBL] [Abstract][Full Text] [Related]
6. A Bayesian predictive strategy for an adaptive two-stage design in phase II clinical trials. Sambucini V Stat Med; 2010 Jun; 29(13):1430-42. PubMed ID: 20099246 [TBL] [Abstract][Full Text] [Related]
9. Frequentist performance of Bayesian inference with response-adaptive designs. Lecoutre B; Derzko G; Elqasyr K Stat Med; 2010 Dec; 29(30):3219-31. PubMed ID: 21170916 [TBL] [Abstract][Full Text] [Related]
10. Frequentist evaluation of group sequential clinical trial designs. Emerson SS; Kittelson JM; Gillen DL Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678 [TBL] [Abstract][Full Text] [Related]
11. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Willan A; Kowgier M Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843 [TBL] [Abstract][Full Text] [Related]
12. Sample size for two-stage studies with maintenance therapy. Feng W; Wahed AS Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105 [TBL] [Abstract][Full Text] [Related]
13. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority. Shao Y; Mukhi V; Goldberg JD Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052 [TBL] [Abstract][Full Text] [Related]
14. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Brannath W; Zuber E; Branson M; Bretz F; Gallo P; Posch M; Racine-Poon A Stat Med; 2009 May; 28(10):1445-63. PubMed ID: 19266565 [TBL] [Abstract][Full Text] [Related]